Scaldis Pharma
Timeline
10 events since 2023Filings
Financial
Permits
Establishments
2023202420252026
Deadline for the 2026 accounts: 31-07-2027
2026
Registered in the Peppol Directory Reachable for e-invoices through 0208:0803923429
Annual accounts 2025 filed NBBmicro format · 31 days before the deadline
2025
Weakest financial year net -€14,039 The net result drops to -€14,039, the lowest from 2023 to 2025.
Environmental permit refused Bomen vellen die geen deel uitmaken van een bos en/of bodemreliëf wijzigen, Functiewijziging zonder verbouwingswerken, Nieuwbouw van bijgebouwen, niet-overdekte lage constructies en andere handelingen · Aalst
Annual accounts 2024 filed PDFmicro format · 55 days before the deadline
2024
Highest result from 2023 to 2025 net €24,009 ▲319% The operating result of €34,782 and the net result of €24,009 are both a record.
Liquidity more than doubled current ratio 3.01 The current ratio rises from 1.34 to 3.01. Short-term debt falls from €24,701 to €15,690.
Annual accounts 2023 filed PDFmicro format · 32 days before the deadline
2023
IncorporationFounding capital of €5,000 · Founder: · Appointment: (director) · published on 17-07-20234 points ▸
- Founding capital, €5,000
- Founder,
- Board rule, 1
- Director appointment, (director (not named in the articles))
- The deed holds 1 more point.
First establishment Qualicon Development, Kapittelstraat 75, Aalst
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank